Accutane & Birth Control: Yaz, Yasmin & Diane-35 – Dying for Better Skin!


Julian Cocciolone Lost His Life to Suicide on Accutane

Dying for better skin
A look at the dangerous – and sometimes deadly – side-effects…

The Australian news show “Sunday Night” has just aired an excellent investigative report on Accutane, and the birth control pills Yasmin, Yaz, Diane-35, all being prescribed for acne. Yet the drugs are killing the young users by either suicide or strokes. Find the link to the excellent piece below.

About three weeks ago on August 17 the Daily Mail out of London published an article by a “doctor” stating that the acne drug, Accutane, which carries a warning for suicide, is still worth trying (–acne-drug-Roaccutane-worth-trying.html) The following day on August 18 I posted a reply to that article titled “Accutane, with Black Box Warning for suicide, is still worth trying???” questioning why, with such a serious warning would anyone want to try this deadly drug? (

But last week I was contacted by our New Zealand Director for the International Coalition for Drug Awareness, Tracy Lee, who shared with me the following television investigative report from the program “Sunday Night” out of Australia. Well when I saw it aired on August 18 it was easy to put two and two together to see why the Daily Mail article came out the day before. Clearly the drug maker had caught wind this news expose was coming out on the 18th and they wanted to head off the bad publicity. I see this all the time.

I strongly urge you to watch the following very well done half hour television investigative report on the dangers of, not only Accutane, but also the birth control pills Diane-35, Yasmin ,Yaz, which are being prescribed for acne as well and killing the young users via strokes.

Because Accutane is known to produce drops in blood sugar producing hypoglycemia it is easy to understand how it can produce both depression and suicide. But also keep in mind that the depression caused by the Accutane can lead to an additional prescription for antidepressants to treat the medication-induced depression which will in turn magnify the suicidal tendencies produced by the first drug.

You will find that Julian’s father became so completely distraught over Julian’s death that he took his own life. Let’s hope and pray that he was not given antidepressants which pushed him over the edge to suicide thus causing prescription drug-induced suicide to take the lives of half of this family.

WARNING: In sharing this information about adverse reactions to antidepressants I always recommend that you also give reference to my CD on safe withdrawal, Help! I Can’t Get Off My Antidepressant!, so that we do not have more people dropping off these drugs too quickly – a move which I have long warned can be even more dangerous than staying on the drugs! The FDA warns that any abrupt change in dose of an antidepressant can produce suicide, hostility or psychosis. And these reactions can come on very rapidly! Find the CD here:

Ann Blake Tracy, Executive Director,
International Coalition for Drug Awareness &
Author: ”Prozac: Panacea or Pandora? – Our Serotonin Nightmare – The Complete Truth of the Full Impact of Antidepressants Upon Us & Our World” & Withdrawal CD “Help! I Can’t Get Off My Antidepressant!”


Accutane, with Black Box Warning for suicide, is still worth trying???

Zit Face

Accutane, with Black Box Warning for suicide, is still worth trying???

According to an article in the Daily Mail written by a doctor the drug given for acne “Acutance is still worth trying” … a deadly drug with a Black Box Warning for suicide!

My opinion? I am absolutely appalled that the Daily Mail would stoop so low as to print such rubbish! Talk about a drug infomercial! Anyone with a functioning brain who can read research knows full well how Accutane produces depression and suicide – it produces drastic drops in blood sugar long known to be involved not only in depression, but many psychiatric symptoms.

Accutane is an extremely dangerous drug known to produce suicide, birth defects and many other serious reactions and what is worse is there is absolutely no need for it. All anyone with acne needs to do is use simple natural products that are safe. One of the best would be ionic silver, one of the best antibiotics ever known to man. Why risk one’s life and health by using such a deadly and dangerous drug that carries a Black Box Warning for suicide?

Original article:–acne-drug-Roaccutane-worth-trying.html

Ann Blake Tracy, Executive Director,
International Coalition for Drug Awareness &
Author: “Prozac: Panacea or Pandora? – Our Serotonin Nightmare – The Complete Truth of the Full Impact of Antidepressants Upon Us & Our World” & Withdrawal CD “Help! I Can’t Get Off My Antidepressant!”

Hassett vs. Leeds General Infirmary (LGI)

Hassett vs. Leeds General Infirmary (LGI)

Man Claims he Became Psychotic on Accutane

Luke Hassett, 22, who was diagnosed as being a paranoid schizophrenic after taking Roaccutane, is to sue Leeds General Infirmary and the clinician who prescribed him the drug.

Hassett vs. Leeds General Infirmary (LGI)


Man Claims he Became Psychotic on Accutane

A patient is suing a hospital for giving him a controversial acne drug similar to the one prescribed to an American teenager who flew an aeroplane into the 28th floor of a skyscraper in a copycat 11 September attack.

Luke Hassett, 22, who was diagnosed as being a paranoid schizophrenic after taking Roaccutane, is to sue Leeds General Infirmary and the clinician who prescribed him the drug. Mr Hassett, one of hundreds of UK patients who claim to have suffered long-term adverse side-effects from taking the drug, decided to act after it was confirmed that Charles Bishop, the 15-year-old who flew into the Bank of America Plaza in Tampa, Florida, in January, had been taking Accutane, the American brand.

Last week lawyers for the Bishop family launched a $70m (£48m) law suit against Roche, makers of the drug, alleging that the medication was responsible for causing their son to commit suicide.

Labelling on Roaccutane in the UK and Accutane in the US warns that the drug can cause “depression, psychosis and, rarely, suicidal ideation, suicide attempts and suicide”. Other side-effects include painful joints, headaches and hair loss. The drug is extremely effective in many cases, but it has been linked to at least 138 suicides and many more suicide attempts.

Mr Hassett, who now lives in a psychiatric unit in Trafford General Hospital, Manchester, had no history of mental problems before he was prescribed Roaccutane for what he claims was mild acne in 1999. Subsequently, he became psychotic and had to be sectioned under the Mental Health Act. He is now on anti-psychotic medication and is allowed home for just four hours each day.

According to a US Food and Drugs Administration memo on Accutane issued in 1990: “The magnitude of injury and death has been great and permanent, with 11,000 to 13,000 Accutane-related abortions and 900 to 1,100 Accutane-related birth defects.” In the UK, where tens of thousands of young people have been treated, there have been around 1,200 “adverse drug reactions” reported to the Medicines Control Agency, including 15 suicides.

Mr Hassett is being backed by Roaccutane action groups in the UK and Ireland, which have around 2,000 members reporting long-term adverse side-effects from taking the drug. They believe a court action will help them gain access to early research into Roaccutane.

The dermatological unit at Leeds has been at the forefront of research into Roaccutane. Trials there, which Roche helped to fund, were instrumental in the drug being given a licence in 1983. However, that licence states that it may be prescribed only for severe forms of acne.

But, in the UK, inquiries by The Independent have established that Roaccutane is routinely prescribed for use beyond the purpose for which it was licensed in 1983. Then, it was approved for “cystic and conglobate acne and severe acne which has failed to respond to an adequate course of antibiotics”.

Between 1983 and 1986 at Leeds General Infirmary (LGI) dermatological unit, where Mr Hassett was treated, 79 per cent of prescriptions for Roaccutane went to people suffering from severe acne. By 1995, however, according to a paper published by the Leeds team, 74 per cent of Roaccutane prescriptions were being given to the LGI patients with only mild or moderate forms of the condition and only 16 per cent of the total prescribed were severe sufferers.

Campaigners say that prescribing of the drug should return to the limitations laid down in its licence until more research is carried out.
The hospital in Leeds said it could not comment while under threat of legal action. A spokeswoman for Roche said there was no evidence of any side-effects attributable to the drug.

“We have had external scientists and internal scientists look into the side-effects and we have found no causal relationship between Roaccutane and any psychiatric events, from depression to suicide.”

Roche said many of the people likely to take Roaccutane–emotional adolescents with low self-esteem caused by acne–were more likely to become depressed than the average youngster.

4/19/2001 – April Edition of ICFDA now Online

Twenty-three new articles from the past month have just been
selected from newspapers across the country and posted our
ICFDA site at

Included among them are two articles that offer proof there are
safer ways to treat depression then by taking pills. One is from
Newsweek entitled “Nourishing Your Brain,” which discusses
studies showing that fats in fish and walnuts can ward off
depression. Another from Reuters showing how aerobic
exercise effectively treats depression.

You will also want to read how a world-renowned scientist saw
his job offer evaporate after he warned that the popular
antidepressant Prozac might trigger suicide. The manufacturer
is an important donor to a mental health institute associated with
the university who courted the doctor. Read “Prozac Critic Sees U
of T Job Revoked.”

Have you seen the ads for Serafem?—the new “cure” for PMDD,
a mental disorder that has yet to be proven to exist? Careful, it’s
just repackaged Prozac in pretty, new pink coating. Be sure to
read the riveting expose by Kelly O’Meara entitled “Misleading

Plus, there’s new information on Viagra, Rezulin, Accutane, MMR
vaccinations and more.


10/09/2000 – Congressman attributes son’s suicide to Accutane

Lawmaker tells of acne drug’s risk

Rep. Bart Stupak.

NBC’s Dr. Bob Arnot discusses the possible health risks of Accutane and
alternative treatments for severe cases of acne.

Congressman attributes
son’s suicide to Accutane


TRAVERSE CITY, Mich., Oct. 5. A Michigan congressman whose
17-year-old son committed suicide earlier this year went public Thursday with
criticism of the Food and Drug Administration, charging on NBC’s Today
show that the agency had failed to warn consumers that the popular acne
medicine Accutane may cause depression.

If it can happen to our family it certainly can happen to you, and we
don’t want anyone to have to go through that. REP. BART STUPAK

BART STUPAK JR., known as B.J., shot himself in the head with his
father’s gun in the early hours of May 14. Stupak, a popular football player,
killed himself after a prom-night party.

His father, Rep. Bart Stupak, a four-term Democrat from Menominee,
said Thursday that he blames Accutane, a powerful acne drug B.J. had taken
for six months prior to his death. We knew our son, we loved our son, he

The congressman and his wife, Laurie, said they had considered every
possible explanation for B.J.’s suicide and the only thing we can find is


In 1998, the Food and Drug Administration advised doctors who
prescribe Accutane to watch their patients for signs of depression.
Afterward, the company notified doctors that the drug may cause depression,
psychosis, and, rarely, suicidal ideation, suicide attempts and suicide.

But Stupak said the FDA had done a poor job spreading the word. B.J.’s
medication package included no warning and the doctor didn’t tell the parents
about the link to depression, his father said.

If it can happen to our family it certainly can happen to you, and we
don’t want anyone to have to go through that, Stupak said.

Hoffmann-La Roche, which manufactures Accutane, contends no
link has been proven between the drug and depression or suicide. In 1998, the
company argued that more than 4 million Americans have taken Accutane since
it was approved in 1982, and the possible side effect is very rare. It said
teen-agers, prime acne sufferers, often suffer depression, and hormones
involved with acne also may contribute to depression.

B.J.’s death stunned family and friends. In the Today interview,
his parents said he was a happy young man with a bright future.


This is contrary to everything he lived for, everything he thought,
everything he wanted in life … completely out of character for him, Stupak
said. He would not do something like this.

B.J. left no note and the autopsy showed no drugs in his system,
although he apparently had taken a couple of drinks.

The only suggestion of odd behavior came the night before his death.
During a party following his junior prom, B.J. began reading the Bible and
said he wasn’t going to college because of his grades, and that his parents
probably hated him for that, according to an account on the Today program.
The Stupaks said there was no reason for him to think such a thing.

An FDA science advisory panel last month suggested requiring
Hoffman-LaRoche to give patients information about potential risks, agency
drug chief Janet Woodcock said.


But Woodcock said there still was insufficient data to establish a
definite connection between Accutane and depression or suicide.

It’s really hard to nail this down, she said in a telephone
interview Wednesday. The bottom line is there is evidence against there
being a link and evidence for being a link.

During the advisory panel meeting, FDA staffers presented evidence
that some people had become depressed when taking the drug and had gotten
over their depression after stopping use of the drug, Woodcock said.

But experts for Hoffman-LaRoche countered with evidence suggesting no
link, she said. The committee recommended further study.

The Associated Press contributed to this report.

9/27/2000 – Further study on Accutane’s mental effects

Once again we ask how many children are being prescribed antidepressants due
to the effects of their acne medication?

Further study urged on Accutane, mental effects
Updated 9:07 PM ET September 19, 2000By Lisa Richwine

GAITHERSBURG, Md. (Reuters) – A federal advisory panel Tuesday recommended
further study to shed light on whether some psychiatric problems may be
linked to Roche Holding Ltd.’s prescription acne drug Accutane.

Patients and physicians also could benefit from new efforts to boost
awareness that Accutane may be linked to cases of depression, mood disorders
or suicide, panel members said. Some suggested a plain-English pamphlet
attached to Accutane packaging that would explain signs of depression or
other problems.

Since 1998, Accutane has come with a warning that users have reported
depression, suicidal thoughts or mood disorders. But the label notes that the
link is uncertain.

Neither the Food and Drug Administration nor Roche could provide evidence
settling the question of whether there is a certain connection. A large
number of patients taking Accutane are teenagers, a group already commonly
affected by depression.

The data “suggest an association with Accutane but do not allow a definitive
determination;” said Diane Wysowski of the FDA.

Accutane, made by Roche unit Hoffmann-La Roche Inc., has been sold in the
United States for nearly two decades and is widely known to cause birth
defects. On Monday, the advisory panel urged health officials to limit
prescriptions for Accutane in order to minimize pregnancies among women
treated with the drug.

The panel, a group of outside experts that advises the FDA, said evidence of
psychiatric side effects were much less certain and did not require such
extensive measures.

Further study might provide clues, particularly by providing signs of whether
certain Accutane patients are more at risk for psychiatric effects, panel
members said.

Also, a federally approved medication guide that gives consumer-friendly
information about depression could help patients recognize symptoms, panel
members said. The committee also suggested new efforts to advise doctors of
depression risks and urge them to tell patients about potential problems.

The FDA usually follows its panels’ advice.

Roche Vice President Russell Ellison said the company would meet with FDA
officials to discuss the panel suggestions. Regarding new research, Ellison
said Roche "will be discussing with FDA what we think is useful, and
what has the best chance of reducing uncertainty the most."

Roche also presented data on a new once-a-day formulation of Accutane that
can be taken with or without food. Directions for the current version of
Accutane, Roche’s second-best-selling product, are for twice-a-day with food.

Roche said the new formulation may be more convenient for patients. The FDA
is considering whether to approve the newer version, but the agency did not
ask the panel’s input on whether it should go to market. REUTERS

5/23/2000 Accutane May Be Linked To Depression, Suicide

In case you missed this I wanted to send this out again. I feel it is very
important to know. There are too many children on this type of medication and
little knowledge of these serious side effects to this drug. How many
children are ending up on antidepressants as a result of their acne meds?

Ann Blake-Tracy

FDA Reports Accutane May Be Linked To Depression, Suicide

WASHINGTON, MD — February 26, 1998 — The United States Food and Drug
Administration is advising consumers and health care providers of new
safety information regarding the prescription anti-acne drug Accutane
(isotretinoin) and isolated reports of depression, psychosis and rarely
suicidal thoughts and actions.

Accutane was approved in 1982 to treat only a very special type of acne —
severe nodular acne that has not responded to other therapies.

Although the Accutane label already included information regarding
depression as a possible adverse reaction, the agency felt health care
providers and others needed additional information as a result of adverse
event reports the agency has received.

FDA and the drug manufacturer are strengthening this label warning, even
though it is difficult to identify the exact cause of these problems. Such
problems could already be more common among the patient populations likely
to be on the drug.

However, because some patients who reported depression also reported that
the depression subsided when they stopped taking the drug and came back
when they resumed taking it, the agency and the manufacturer felt the
strengthened labelling was warranted as a precautionary measure.

Given the complex nature of depression and suicidal conditions, the new
label information will advise health care providers that merely
discontinuing the drug may be insufficient to remedy these adverse events
and that further evaluation may be needed.